Pathogenic mechanisms of IgE-mediated inflammation in self-destructive autoimmune responses

References

• Johansson, S. G. 2000. The discovery of IgE. J. Allergy. Clin. Immunol. 137: 1671–1673
   Web of Science ®Google Scholar
• Gould, H. J., and B. J. Sutton. 2008. IgE in allergy and asthma today. Nat. Rev. Immunol. 8: 205–217
   PubMed Web of Science ®Google Scholar
• Palm, N. W., R. K. Rosenstein, and R. Medzhitov. 2012. Allergic host defences. Nature. 484: 465–472
   PubMed Web of Science ®Google Scholar
• Permin, H., and A. Wiik. 1978. The prevalence of IgE antinuclear antibodies in rheumatoid arthritis and systemic lupus erythematosus. Acta. Pathol. Microbiol. Scand. C. 86C: 245–249
   PubMedGoogle Scholar
• Messingham, K. A., H. M. Holahan, and Fairley J. A. 2014. Unraveling the significance of IgE autoantibodies in organ-specific autoimmunity: lessons learned from bullous pemphigoid. Immunol. Res. 59: 273–278
   PubMed Web of Science ®Google Scholar
• Ujiie, H. 2015. IgE autoantibodies in bullous pemphigoid: supporting role, or leading player? J. Dermatol. Sci. 78: 5–10
   PubMed Web of Science ®Google Scholar
• Altrichter, S., H. J. Peter, D. Pisarevskaja, et al 2011. IgE mediated autoallergy against thyroid peroxidase–a novel pathomechanism of chronic spontaneous urticaria? PLoS One. 6: e14794
   PubMed Web of Science ®Google Scholar
• Chang, T. W., C. Chen, C. J. Lin, et al 2015. The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria. J. Allergy. Clin. Immunol. 135: 337–342
   PubMed Web of Science ®Google Scholar
• Tang, T. S., T. Bieber, and H. C. Williams. 2012. Does “ uot; play a role in atopic dermatitis? ” play a role in atopic. J. Allergy. Clin. Immunol. 129: 1209–1215 e2
   PubMed Web of Science ®Google Scholar
• Henault, J., J. M. Riggs, J. L. Karnell, et al 2016. Self-reactive IgE exacerbates interferon responses associated with autoimmunity. Nat. Immunol. 17: 196–203
   PubMed Web of Science ®Google Scholar
• Higgs, B. W., Z. Liu, B. White, et al 2011. Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway. Ann. Rheum. Dis. 70: 2029–2036
   PubMed Web of Science ®Google Scholar
• Jego, G., A. K. Palucka, J. P. Blanck, et al 2003. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity. 19: 225–234
   PubMed Web of Science ®Google Scholar
• Fairley, J. A., C. L. Baum, D. S. Brandt, and K. A. Messingham. 2009. Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab. J. Allergy. Clin. Immunol. 123: 704–705
   PubMed Web of Science ®Google Scholar
• Maurer, M., K. Rosen, and H. J. Hsieh. 2013. Omalizumab for chronic urticaria. N. Engl. J. Med. 368: 2530
   PubMed Web of Science ®Google Scholar
• Saini, S., K. E. Rosen, H. J. Hsieh, et al 2011. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. J. Allergy. Clin. Immunol. 128: 567–573 e1
   PubMed Web of Science ®Google Scholar
• Yu, K. K., A. B. Crew, K. A. Messingham, et al 2014. Omalizumab therapy for bullous pemphigoid. J. Am. Acad. Dermatol. 71: 468–474
   PubMed Web of Science ®Google Scholar
• Parks, C. G, R. E. Biagini, G. S. Cooper, et al 2010. Total serum IgE levels in systemic lupus erythematosus and associations with childhood onset allergies. Lupus.19: 1614–1622
   PubMed Web of Science ®Google Scholar
• Rebhun, J., Jr., F. Quismorio, E. Dubois, and D. C. Heiner. 1983. Systemic lupus erythematosus activity and IgE. Ann. Allergy. 50: 34–36
   PubMedGoogle Scholar
• Laurent, J., G. Lagrue, and A. Sobel. 1986. Increased serum IgE levels in patients with lupus nephritis. Am J Nephrol. 6: 413–414
   PubMed Web of Science ®Google Scholar
• Liphaus, B. L., A. A. Jesus, C. A. Silva, et al 2012. Increased IgE serum levels are unrelated to allergic and parasitic diseases in patients with juvenile systemic lupus erythematosus. Clinics (Sao Paulo). 67: 1275–1280
   PubMed Web of Science ®Google Scholar
• Atta, A. M., C. P. Sousa, E. M. Carvalho, and M. L. Sousa-Atta. 2004. Immunoglobulin E and systemic lupus erythematosus. Braz. J. Med. Biol. Res. 37: 1497–1501
   PubMed Web of Science ®Google Scholar
• Elkayam, O., R. Tamir, A. I. Pick, and A. Wysenbeek. 1995. Serum IgE concentrations, disease activity, and atopic disorders in systemic lupus erythematosus. Allergy. 50: 94–96
   PubMed Web of Science ®Google Scholar
• Wozniacka, A., A. Sysa-Jedrzejowska, E. Robak, et al 2003. Allergic diseases, drug adverse reactions and total immunoglobulin E levels in lupus erythematosus patients. Mediators Inflamm. 12: 95–99
   PubMed Web of Science ®Google Scholar
• Morton, S., B. Palmer, K. Muir, and R. J. Powell. 1998. IgE and non-IgE mediated allergic disorders in systemic lupus erythematosus. Ann. Rheum. Dis. 57: 660–663
   PubMed Web of Science ®Google Scholar
• Dema, B., C. Pellefigues, S. Hasni, et al 2014. Autoreactive IgE is prevalent in systemic lupus erythematosus and is associated with increased disease activity and nephritis. PLoS One. 9: e90424
   PubMed Web of Science ®Google Scholar
• Zhu, H., H. Luo, M. Yan, et al 2015. Autoantigen microarray for high-throughput autoantibody profiling in systemic lupus erythematosus. Genomics Proteomics Bioinformatics. 13: 210–218
   PubMed Web of Science ®Google Scholar
• Rhyner, C., I. Daigle, and R. Crameri. 2011. Auto-reactive IgE responses to acidic ribosomal P(2) protein in systemic lupus erythematosus. Allergy. 66: 1127–1129
   PubMed Web of Science ®Google Scholar
• Okamura, M., Y. Kanayama, K. Amastu, et al 1993. Significance of enzyme linked immunosorbent assay (ELISA) for antibodies to double stranded and single stranded DNA in patients with lupus nephritis: correlation with severity of renal histology. Ann. Rheum. Dis. 52: 14–20
   PubMed Web of Science ®Google Scholar
• Tuma, S. N., F. Llach, S. Sostrin, et al 1981. Glomerular IgE deposits in patients with lupus nephritis. Am J Nephrol. 1: 31–36
   PubMed Web of Science ®Google Scholar
• Schmidt, E., and D. Zillikens. 2013. Pemphigoid diseases. Lancet. 381: 320–332
   PubMed Web of Science ®Google Scholar
• Dimson, O. G., G. J. Giudice, C. L. Fu, et al 2003. Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid. J. Invest. Dermatol. 120: 784–788
   PubMed Web of Science ®Google Scholar
• Dopp, R., E. Schmidt, I. Chimanovitch, et al 2000. IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity. J. Am. Acad. Dermatol. 42: 577–583
   PubMed Web of Science ®Google Scholar
• Iwata, Y., K. Komura, M. Kodera, et al 2008. Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid. Arch. Dermatol. 144: 41–48
   PubMedGoogle Scholar
• Provost, T. T., and, Jr.T. B. Tomasi. 1974. Immunopathology of bullous pemphigoid. Basement membrane deposition of IgE, alternate pathway components and fibrin. Clin. Exp. Immunol. 18: 193–200
   PubMed Web of Science ®Google Scholar
• Fairley, J. A., C. T. Burnett, C. L. Fu, et al 2007. A pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu/nu mice. J. Invest. Dermatol. 127: 2605–2611
   PubMed Web of Science ®Google Scholar
• Dvorak, A. M., Jr., M. C. Mihm, J. E. Osage, et al 1982. Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient. J. Invest. Dermatol. 78: 91–101
   PubMed Web of Science ®Google Scholar
• Wintroub, B. U., Jr., M. C. Mihm, E. J. Goetzl, et al 1978. Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid. N. Engl. J. Med. 298: 417–421
   PubMed Web of Science ®Google Scholar
• Zuberbier, T., W. Aberer, R. Asero, et al 2014. Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 69: e1–29
   PubMed Web of Science ®Google Scholar
• Confino-Cohen, R., G. Chodick, V. Shalev, et al 2012. Chronic urticaria and autoimmunity: associations found in a large population study. J. Allergy. Clin. Immunol. 129: 1307–1313
   PubMed Web of Science ®Google Scholar
• Kolkhir, P., D. Pogorelov, O. Olisova, and Maurer M. 2016. Comorbidity and pathogenic links of chronic spontaneous urticaria and systemic lupus erythematosus - a systematic review. Clin. Exp. Allergy. 46: 275–287
   PubMed Web of Science ®Google Scholar
• Kaplan, A. P. 2012. Treatment of chronic spontaneous urticaria. Allergy Asthma Immunol. Res. 4: 326–331
   PubMed Web of Science ®Google Scholar
• Stitt, J. M., and S. C. Dreskin. 2013. Urticaria and autoimmunity: where are we now? Curr. Allergy. Asthma. Rep. 13: 555–562
   PubMed Web of Science ®Google Scholar
• Malmros, H. 1946. *Autoserumtest (AST). Nord Med: LAEGEFORENINGENS FORLAG ESPLANADEN 8A, DK-1263 Copenhagen K, Denmark; p. 150–152
   Google Scholar
• Leznoff, A., R. G. Josse, J. Denburg, and J. Dolovich. 1983. Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch. Dermatol. 119: 636–640
   PubMed Web of Science ®Google Scholar
• Hatada, Y., J. Kashiwakura, K. Hayama, et al 2013. Significantly high levels of anti-dsDNA immunoglobulin E in sera and the ability of dsDNA to induce the degranulation of basophils from chronic urticaria patients. Int. Arch. Allergy. Immunol. 161: 154–158
   PubMed Web of Science ®Google Scholar
• Altrichter, S., E. Kriehuber, J. Moser, et al 2008. Serum IgE autoantibodies target keratinocytes in patients with atopic dermatitis. J. Invest. Dermatol. 128: 2232–2239
   PubMed Web of Science ®Google Scholar
• Concha, L. B., C. C. Chang, A. M. Szema, et al 2004. IgE antithyroid antibodies in patients with Hashimoto's disease and chronic urticaria. Allergy. Asthma. Proc. 25: 293–296
   PubMed Web of Science ®Google Scholar
• Ferrer, M., J. M. Nunez-Cordoba, E. Luquin, et al 2010. Serum total tryptase levels are increased in patients with active chronic urticaria. Clin. Exp. Allergy. 40: 1760–1766
   PubMed Web of Science ®Google Scholar
• Kaufman, L. D., B. L. Gruber, M. J. Marchese, and J. R. Seibold. 1989. Anti-IgE autoantibodies in systemic sclerosis (scleroderma). Ann. Rheum. Dis. 48: 201–205
   PubMed Web of Science ®Google Scholar
• Guo, J., B. Rapoport, and S. M. McLachlan. 1997. Thyroid peroxidase autoantibodies of IgE class in thyroid autoimmunity. Clin. Immunol. Immunopathol. 82: 157–162
   PubMedGoogle Scholar
• Sato, A., Y. Takemura, T. Yamada, et al 1999. A possible role of immunoglobulin E in patients with hyperthyroid Graves' disease. J. Clin. Endocrinol. Metab. 84: 3602–3605
   PubMed Web of Science ®Google Scholar
• Mikol, D. D., C. Ditlow, D. Usatin, et al 2006. Serum IgE reactive against small myelin protein-derived peptides is increased in multiple sclerosis patients. J. Neuroimmunol. 180: 40–49
   PubMed Web of Science ®Google Scholar
• Zeller, S., C. Rhyner, N. Meyer, et al 2009. Exploring the repertoire of IgE-binding self-antigens associated with atopic eczema. J. Allergy. Clin. Immunol. 124: 278–285. 85 e1-7
   PubMed Web of Science ®Google Scholar
• Hradetzky, S., L. M. Roesner, H. Balaji, et al 2014. Cytokine effects induced by the human autoallergen α-NAC. J. Invest. Dermatol. 134: 1570–1578
   PubMed Web of Science ®Google Scholar
• Muro, Y. 2001. Autoantibodies in atopic dermatitis. J. Dermatol. Sci. 25: 171–178
   PubMed Web of Science ®Google Scholar
• Valenta, R., S. Natter, S. Seiberler, et al 1998. Molecular characterization of an autoallergen, Hom s 1, identified by serum IgE from atopic dermatitis patients. J. Invest. Dermatol. 111: 1178–1183
   PubMed Web of Science ®Google Scholar
• Kinaciyan, T., S. Natter, D. Kraft, et al 2002. IgE autoantibodies monitored in a patient with atopic dermatitis under cyclosporin A treatment reflect tissue damage. J. Allergy. Clin. Immunol. 109: 717–719
   PubMed Web of Science ®Google Scholar
• Aichberger, K. J., I. Mittermann, R. Reininger, et al 2005. Hom s 4, an IgE-reactive autoantigen belonging to a new subfamily of calcium-binding proteins, can induce Th cell type 1-mediated autoreactivity. J. Immunol. 175: 1286–1294
   PubMed Web of Science ®Google Scholar
• Ochs, R. L., Y. Muro, Y. Si, et al 2000. Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions. J. Allergy. Clin. Immunol. 105: 1211–1220
   PubMed Web of Science ®Google Scholar
• Valenta, R., D. Maurer, R. Steiner, et al 1996. Immunoglobulin E response to human proteins in atopic patients. J. Invest. Dermatol. 107: 203–208
   PubMed Web of Science ®Google Scholar
• Hradetzky, S., L. M. Roesner, A. Heratizadeh, et al 2015. Differential cytokine induction by the human skin-associated autoallergen thioredoxin in sensitized patients with atopic dermatitis and healthy control subjects. J. Allergy. Clin. Immunol. 135: 1378–1380. e1-5
   PubMed Web of Science ®Google Scholar
• Cipriani, F., G. Ricci, M. C. Leoni, et al 2014. Autoimmunity in atopic dermatitis: biomarker or simply epiphenomenon?. J. Dermatol. 41: 569–576
   PubMed Web of Science ®Google Scholar
• de Vries, J. E., J. Punnonen, B. G. Cocks, et al 1993. Regulation of the human IgE response by IL4 and IL13. Research in Immunology. 144: 597–601
   PubMedGoogle Scholar
• Jabara, H. H., S. M. Fu, R. S. Geha, and D. Vercelli. 1990. CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J. Exp. Med. 172: 1861–1864
   PubMed Web of Science ®Google Scholar
• McKenzie, A. N., J. A. Culpepper, R. de Waal Malefyt, et al 1993. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc. Natl. Acad. Sci. U. S. A. 90: 3735–3739
   PubMed Web of Science ®Google Scholar
• Durandy, A., and T. Honjo. 2001. Human genetic defects in class-switch recombination (hyper-IgM syndromes). Curr. Opin. Immunol. 13: 543–548
   PubMed Web of Science ®Google Scholar
• Chaudhuri, J., M. Tian, C. Khuong, et al 2003. Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature. 422: 726–730
   PubMed Web of Science ®Google Scholar
• Boraschi, D., and C. A. Dinarello. 2006. IL-18 in autoimmunity: review. Eur. Cytokine. Netw. 17: 224–252
   PubMed Web of Science ®Google Scholar
• Yoshimoto, T., H. Mizutani, H. Tsutsui, et al 2000. IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6. Nat. Immunol. 1: 132–137
   PubMed Web of Science ®Google Scholar
• Enoksson, S. L., E. K. Grasset, T. Hagglof, et al 2011. The inflammatory cytokine IL-18 induces self-reactive innate antibody responses regulated by natural killer T cells. Proc. Natl. Acad. Sci. U. S. A. 108: E1399–E1407
   PubMed Web of Science ®Google Scholar
• Hoshino, T., H. Yagita, J. R. Ortaldo, et al 2000. In vivo administration of IL-18 can induce IgE production through Th2 cytokine induction and up-regulation of CD40 ligand (CD154) expression on CD4+ T cells. Eur. J. Immunol. 30: 1998–2006
   PubMed Web of Science ®Google Scholar
• Ettinger, R., G. P. Sims, R. Robbins, et al 2007. IL-21 and BAFF/BLyS synergize in stimulating plasma cell differentiation from a unique population of human splenic memory B cells. J. Immunol. 178: 2872–2882
   PubMed Web of Science ®Google Scholar
• Litinskiy, M. B., B. Nardelli, D. M. Hilbert, et al 2002. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3: 822–829
   PubMed Web of Science ®Google Scholar
• Vincent, F. B., E. F. Morand, P. Schneider, and F. Mackay. 2014. The BAFF/APRIL system in SLE pathogenesis. Nat. Rev. Rheumatol. 10: 365–373
   PubMed Web of Science ®Google Scholar
• Wong, C. K., P. T. Wong, L. S. Tam, et al 2010. Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity. J. Clin. Immunol. 30: 45–52
   PubMed Web of Science ®Google Scholar
• Dolff, S., W. H. Abdulahad, J. Westra, et al 2011. Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus. Arthritis Res. Ther. 13: R157
   PubMed Web of Science ®Google Scholar
• Sawalha, A. H., K. M. Kaufman, J. A. Kelly, et al 2008. Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus. Ann. Rheum. Dis. 67: 458–461
   PubMed Web of Science ®Google Scholar
• Webb, R., J. T. Merrill, J. A. Kelly, et al 2009. A polymorphism within IL21R confers risk for systemic lupus erythematosus. Arthritis Rheum. 60: 2402–2407
   PubMed Web of Science ®Google Scholar
• Ettinger, R., S. Kuchen, and P. E. Lipsky. 2008. The role of IL-21 in regulating B-cell function in health and disease. Immunol. Rev. 223: 60–86
   PubMed Web of Science ®Google Scholar
• Ettinger, R., G. P. Sims, A. M. Fairhurst, et al 2005. IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J. Immunol. 175: 7867–7879
   PubMed Web of Science ®Google Scholar
• Pene, J., J. F. Gauchat, S. Lecart, et al 2004. Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells. J. Immunol. 172: 5154–5157
   PubMed Web of Science ®Google Scholar
• Ozaki, K., R. Spolski, C. G. Feng, et al 2002. A critical role for IL-21 in regulating immunoglobulin production. Science. 298: 1630–1634
   PubMed Web of Science ®Google Scholar
• Shang, X. Z., K. Y. Ma, J. Radewonuk, et al 2006. IgE isotype switch and IgE production are enhanced in IL-21-deficient but not IFN-gamma-deficient mice in a Th2-biased response. Cell Immunol. 241: 66–74
   PubMed Web of Science ®Google Scholar
• Hiromura, Y., T. Kishida, H. Nakano, et al 2007. IL-21 administration into the nostril alleviates murine allergic rhinitis. J. Immunol. 179: 7157–7165
   PubMed Web of Science ®Google Scholar
• Suto, A., H. Nakajima, K. Hirose, et al 2002. Interleukin 21 prevents antigen-induced IgE production by inhibiting germ line C(epsilon) transcription of IL-4-stimulated B cells. Blood. 100: 4565–4573
   PubMed Web of Science ®Google Scholar
• Kishida, T., Y. Hiromura, M. Shin-Ya, et al 2007. IL-21 induces inhibitor of differentiation 2 and leads to complete abrogation of anaphylaxis in mice. J. Immunol. 179: 8554–8561
   PubMed Web of Science ®Google Scholar
• Gonda, H., M. Sugai, Y. Nambu, et al 2003. The balance between Pax5 and Id2 activities is the key to AID gene expression. J. Exp. Med. 198: 1427–1437
   PubMed Web of Science ®Google Scholar
• Sugai, M., H. Gonda, T. Kusunoki, et al 2003. Essential role of Id2 in negative regulation of IgE class switching. Nat. Immunol. 4: 25–30
   PubMed Web of Science ®Google Scholar
• Erman, B., I. Bilic, T. Hirschmugl, et al 2015. Combined immunodeficiency with CD4 lymphopenia and sclerosing cholangitis caused by a novel loss-of-function mutation affecting IL21R. Haematologica. 100: e216–e219
   PubMed Web of Science ®Google Scholar
• Kotlarz, D., N. Zietara, G. Uzel, et al 2013. Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome. J. Exp. Med. 210: 433–443
   PubMed Web of Science ®Google Scholar
• Salzer, E., A. Kansu, H. Sic, et al 2014. Early-onset inflammatory bowel disease and common variable immunodeficiency-like disease caused by IL-21 deficiency. J. Allergy. Clin. Immunol. 133: 1651–1659 e12
   PubMed Web of Science ®Google Scholar
• Pene, J., L. Guglielmi, J. F. Gauchat, et al 2006. IFN-gamma-mediated inhibition of human IgE synthesis by IL-21 is associated with a polymorphism in the IL-21R gene. J. Immunol. 177: 5006–5013
   PubMed Web of Science ®Google Scholar
• Wood, N., K. Bourque, D. D. Donaldson, et al 2004. IL-21 effects on human IgE production in response to IL-4 or IL-13. Cell Immunol. 231: 133–145
   PubMed Web of Science ®Google Scholar
• Strengell, M., S. Matikainen, J. Siren, et al 2003. IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells. J. Immunol. 170: 5464–5469
   PubMed Web of Science ®Google Scholar
• Harada, M., K. Magara-Koyanagi, H. Watarai, et al 2006. IL-21-induced Bepsilon cell apoptosis mediated by natural killer T cells suppresses IgE responses. J. Exp. Med. 203: 2929–2937
   PubMed Web of Science ®Google Scholar
• Avery, D. T., C. S. Ma, V. L. Bryant, et al 2008. STAT3 is required for IL-21-induced secretion of IgE from human naive B cells. Blood. 112: 1784–1793
   PubMed Web of Science ®Google Scholar
• Caven, T. H., A. Shelburne, J. Sato, et al 2005. IL-21 dependent IgE production in human and mouse in vitro culture systems is cell density and cell division dependent and is augmented by IL-10. Cell Immunol. 238: 123–134
   PubMed Web of Science ®Google Scholar
• Freeman, A. F., D. L. Domingo, and S. M. Holland. 2009. Hyper IgE (Job's) syndrome: a primary immune deficiency with oral manifestations. Oral Dis. 15: 2–7
   PubMed Web of Science ®Google Scholar
• Holland, S. M., F. R. DeLeo, H. Z. Elloumi, et al 2007. STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med. 357: 1608–1619
   PubMed Web of Science ®Google Scholar
• Minegishi, Y., M. Saito, S. Tsuchiya, et al 2007. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 448: 1058–1062
   PubMed Web of Science ®Google Scholar
• Paulson, M. L., A. F. Freeman, and S. M. Holland. 2008. Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3. Curr. Opin. Allergy Clin. Immunol. 8: 527–533
   PubMed Web of Science ®Google Scholar
• Scott, P. 1991. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J. Immunol. 147: 3149–3155
   PubMed Web of Science ®Google Scholar
• Pene, J., F. Rousset, F. Briere, et al 1988. IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2. Proc. Natl. Acad. Sci. U. S. A. 85: 6880–6884
   PubMed Web of Science ®Google Scholar
• Pene, J., F. Rousset, F. Briere, et al 1988. Interleukin 5 enhances interleukin 4-induced IgE production by normal human B cells. The role of soluble CD23 antigen. Eur. J. Immunol. 18: 929–935
   PubMed Web of Science ®Google Scholar
• Xu, L., and P. Rothman. 1994. IFN-gamma represses epsilon germline transcription and subsequently down-regulates switch recombination to epsilon. Int. Immunol. 6: 515–521
   PubMed Web of Science ®Google Scholar
• Kiniwa, M., M. Gately, U. Gubler, et al 1992. Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes. J. Clin. Invest. 90: 262–266
   PubMed Web of Science ®Google Scholar
• Punnonen, J., K. Punnonen, C. T. Jansen, and K. Kalimo. 1993. Interferon (IFN)-alpha, IFN-gamma, interleukin (IL)-2, and arachidonic acid metabolites modulate IL-4-induced IgE synthesis similarly in healthy persons and in atopic dermatitis patients. Allergy. 48: 189–195
   PubMed Web of Science ®Google Scholar
• Liu, N., N. Ohnishi, L. Ni, S. Akira, et al 2003. CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells. Nat. Immunol. 4: 687–693
   PubMed Web of Science ®Google Scholar
• Rubtsov, A. V., K. Rubtsova, A. Fischer, et al 2011. Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c+ B-cell population is important for the development of autoimmunity. Blood. 118: 1305–1315
   PubMed Web of Science ®Google Scholar
• Rubtsova, K., A. V. Rubtsov, L. F. van Dyk, et al 2013. T-box transcription factor T-bet, a key player in a unique type of B-cell activation essential for effective viral clearance. Proc. Natl. Acad. Sci. U. S. A. 110: E3216–E3224
   PubMed Web of Science ®Google Scholar
• Peng, S. L., S. J. Szabo, and L. H. Glimcher. 2002. T-bet regulates IgG class switching and pathogenic autoantibody production. Proc. Natl. Acad. Sci. U. S. A. 99: 5545–5550
   PubMed Web of Science ®Google Scholar
• Sherr, E., E. Macy, H. Kimata, et al 1989. Binding the low affinity Fc epsilon R on B cells suppresses ongoing human IgE synthesis. J Immunol. 142: 481–489
   PubMed Web of Science ®Google Scholar
• McCloskey, N., J. Hunt, R. L. Beavil, et al 2007. Soluble CD23 monomers inhibit and oligomers stimulate IGE synthesis in human B cells. J. Biol. Chem. 282: 24083–24091
   PubMed Web of Science ®Google Scholar
• Saxon, A., Z. Ke, L. Bahati, and R. H. Stevens. 1990. Soluble CD23 containing B cell supernatants induce IgE from peripheral blood B-lymphocytes and costimulate with interleukin-4 in induction of IgE. J. Allergy. Clin. Immunol. 86: 333–344
   PubMed Web of Science ®Google Scholar
• Rosenwasser, L. J., and J. Meng. 2005. Anti-CD23. Clin. Rev. Allergy Immunol. 29: 61–72
   PubMed Web of Science ®Google Scholar
• Pioli, C., L. Gatta, V. Ubaldi, and G. Doria. 2000. Inhibition of IgG1 and IgE production by stimulation of the B cell CTLA-4 receptor. J. Immunol. 165: 5530–5536
   PubMed Web of Science ®Google Scholar
• Butt, D., T. D. Chan, K. Bourne, et al 2015. FAS inactivation releases unconventional germinal center B cells that escape antigen control and drive IgE and autoantibody production. Immunity. 42: 890–902
   PubMed Web of Science ®Google Scholar
• Goldman, J. A., G. A. Klimek, and R. Ali. 1976. Allergy in systemic lupus erythematosus. IgE levels and reaginic phenomenon. Arthritis Rheum. 19: 669–676
   PubMed Web of Science ®Google Scholar
• Sekigawa, I., Y. Tokano, T. Yoshiike, et al 2003. Relationship between serum IgE and autoantibody levels in SLE patients. Clin Exp Rheumatol. 21: 683
   PubMed Web of Science ®Google Scholar
• McNab, F., K. Mayer-Barber, A. Sher, et al 2015. Type I interferons in infectious disease. Nat. Rev. Immunol. 15: 87–103
   PubMed Web of Science ®Google Scholar
• Khamashta, M., J. T. Merrill, V. P. Werth, et al 2016. Sifalimumab, an anti-interferon-alpha monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study. Ann. Rheum. Dis. 75: 1909–1916
   PubMed Web of Science ®Google Scholar
• Furie, R., J. Merrill, V. Werth, et al 2015. Anifrolumab, an anti-interferon alpha receptor monoclonal antibody, in moderate to severe systemic lupus erythematosus (SLE). Arthritis Rheumatol. 67: Abstract number 3223
   Web of Science ®Google Scholar
• Lennert, K., E. Kaiserling, and H. K. Muller-Hermelink. 1975. Letter: T-associated plasma-cells. Lancet. 1: 1031–1032
   PubMed Web of Science ®Google Scholar
• Jarrossay, D., G. Napolitani, M. Colonna, et al 2001. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 31: 3388–3393
   PubMed Web of Science ®Google Scholar
• Means, T. K., E. Latz, F. Hayashi, et al 2005. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 115: 407–417
   PubMed Web of Science ®Google Scholar
• Henault, J., J. Martinez, J. M. Riggs, et al 2012. Noncanonical autophagy is required for type I interferon secretion in response to DNA-immune complexes. Immunity. 37: 986–997
   PubMed Web of Science ®Google Scholar
• Mehta, P., J. Henault, R. Kolbeck, and M. A. Sanjuan. 2014. Noncanonical autophagy: one small step for LC3, one giant leap for immunity. Curr. Opin. Immunol. 26: 69–75
   PubMed Web of Science ®Google Scholar
• Siegal, F. P., N. Kadowaki, M. Shodell, et al 1999. The nature of the principal type 1 interferon-producing cells in human blood. Science. 284: 1835–1837
   PubMed Web of Science ®Google Scholar
• Nunomura, S., Y. Gon, T. Yoshimaru, et al 2005. Role of the FcepsilonRI beta-chain ITAM as a signal regulator for mast cell activation with monomeric IgE. Int. Immunol. 17: 685–694
   PubMed Web of Science ®Google Scholar
• Novak, N., J. P. Allam, T. Hagemann, et al 2004. Characterization of FcepsilonRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis. J. Allergy. Clin. Immunol. 114: 364–370
   PubMed Web of Science ®Google Scholar
• Joffre, O. P., E. Segura, A. Savina, and S. Amigorena. 2012. Cross-presentation by dendritic cells. Nat. Rev. Immunol. 12: 557–569
   PubMed Web of Science ®Google Scholar
• Kilmon, M. A., R. Ghirlando, M. P. Strub, et al 2001. Regulation of IgE production requires oligomerization of CD23. J. Immunol. 167: 3139–3145
   PubMed Web of Science ®Google Scholar
• Miyahara, N., B. J. Swanson, K. Takeda, et al 2004. Effector CD8+ T cells mediate inflammation and airway hyper-responsiveness. Nat. Med. 10: 865–869
   PubMed Web of Science ®Google Scholar
• Mudde, G. C., R. Bheekha, C. A. Bruijnzeel-Koomen. 1995. Consequences of IgE/CD23-mediated antigen presentation in allergy. Immunol. Today. 16: 380–383
   PubMedGoogle Scholar
• Platzer, B., K. G. Elpek, V. Cremasco, et al 2015. IgE/FcepsilonRI-mediated antigen cross-presentation by dendritic cells enhances anti-tumor immune responses. Cell Rep. 10: 1487–1495
   PubMed Web of Science ®Google Scholar
• Hunter, C. A., and S. A. Jones. 2015. IL-6 as a keystone cytokine in health and disease. Nat. Immunol. 16: 448–457
   PubMed Web of Science ®Google Scholar
• Alunno, A., E. Bartoloni, O. Bistoni, et al 2012. Balance between regulatory T and Th17 cells in systemic lupus erythematosus: the old and the new. Clin. Dev. Immunol. 2012: 823085
   PubMedGoogle Scholar
• Gonzalez-Navajas, J. M., J. Lee, M. David, and E. Raz. 2012. Immunomodulatory functions of type I interferons. Nat. Rev. Immunol. 12: 125–135
   PubMed Web of Science ®Google Scholar
• Lopez, P., J. Rodriguez-Carrio, L. Caminal-Montero, et al 2016. A pathogenic IFNα, BLyS and IL-17 axis in Systemic Lupus Erythematosus patients. Sci. Rep. 6: 20651
   PubMed Web of Science ®Google Scholar
• Bryant, V. L., C. S. Ma, D. T. Avery, et al 2007. Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells. J. Immunol. 179: 8180–8190
   PubMed Web of Science ®Google Scholar
• Ding, J., H. Komatsu, A. Wakita, et al 2004. Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin. Blood. 103: 4198–4200
   PubMed Web of Science ®Google Scholar
• Charles, N., D. Hardwick, E. Daugas, et al 2010. Basophils and the T helper 2 environment can promote the development of lupus nephritis. Nat. Med. 16: 701–707
   PubMed Web of Science ®Google Scholar
• Camussi, G., C. Tetta, and J. Benveniste. 1982. Detection of basophil sensitization by IgE antibodies to nuclear antigens in connective tissue diseases. Int. Arch. Allergy. Appl. Immunol. 69: 358–362
   PubMedGoogle Scholar
• Rodriguez Gomez, M., Y. Talke, N. Goebel, et al 2010. Basophils support the survival of plasma cells in mice. J. Immunol. 185: 7180–7185
   PubMed Web of Science ®Google Scholar